
Olin Corporation (NYSE:OLN – Free Report) – Stock analysts at KeyCorp issued their Q3 2026 earnings per share (EPS) estimates for shares of Olin in a report released on Thursday, September 10th. KeyCorp analyst S. Tiano expects that the specialty chemicals company will post earnings per share of $0.06 for the quarter. The consensus estimate for Olin’s current full-year earnings is ($0.68) per share. KeyCorp also issued estimates for Olin’s Q4 2026 earnings at ($0.20) EPS and FY2028 earnings at $1.35 EPS.
Other research analysts have also recently issued research reports about the stock. Wall Street Zen cut shares of Olin from a “sell” rating to a “strong sell” rating in a report on Saturday, August 8th. Royal Bank Of Canada lowered their price objective on Olin from $24.00 to $20.00 and set a “sector perform” rating on the stock in a research report on Monday, August 3rd. Citigroup downgraded shares of Olin from a “neutral” rating to an “underperform” rating in a research report on Tuesday, June 30th. Wells Fargo & Company reissued an “equal weight” rating and set a $20.00 target price (down from $25.00) on shares of Olin in a research note on Monday, August 3rd. Finally, Weiss Ratings restated a “sell (d)” rating on shares of Olin in a research report on Wednesday, August 19th. One analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, ten have given a Hold rating and four have assigned a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of “Reduce” and an average price target of $22.62.
Olin Stock Down 1.1%
OLN stock opened at $17.27 on Friday. The stock has a market capitalization of $1.97 billion, a PE ratio of -14.04 and a beta of 1.20. Olin has a 52 week low of $16.73 and a 52 week high of $30.46. The company has a quick ratio of 0.87, a current ratio of 1.42 and a debt-to-equity ratio of 1.77. The firm has a 50 day moving average of $19.57 and a 200 day moving average of $23.56.
Olin (NYSE:OLN – Get Free Report) last posted its quarterly earnings data on Thursday, July 30th. The specialty chemicals company reported ($0.12) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.13 by ($0.25). The company had revenue of $1.74 billion for the quarter, compared to analyst estimates of $1.81 billion. Olin had a negative net margin of 2.08% and a negative return on equity of 4.76%. The business’s revenue was down .9% compared to the same quarter last year. During the same quarter last year, the company earned ($0.01) EPS.
Olin Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 11th. Shareholders of record on Thursday, August 27th will be given a dividend of $0.20 per share. The ex-dividend date is Thursday, August 27th. This represents a $0.80 dividend on an annualized basis and a yield of 4.6%. Olin’s dividend payout ratio is currently -65.04%.
Institutional Trading of Olin
Institutional investors have recently modified their holdings of the stock. Amundi boosted its holdings in Olin by 337.2% during the 1st quarter. Amundi now owns 684,036 shares of the specialty chemicals company’s stock valued at $20,336,000 after acquiring an additional 527,586 shares during the period. Empowered Funds LLC increased its stake in Olin by 1,946.0% during the first quarter. Empowered Funds LLC now owns 435,599 shares of the specialty chemicals company’s stock worth $12,950,000 after purchasing an additional 414,309 shares during the period. Dimensional Fund Advisors LP lifted its position in shares of Olin by 22.4% during the first quarter. Dimensional Fund Advisors LP now owns 5,627,997 shares of the specialty chemicals company’s stock worth $167,311,000 after purchasing an additional 1,031,498 shares in the last quarter. Sei Investments Co. lifted its position in shares of Olin by 132.5% during the first quarter. Sei Investments Co. now owns 169,374 shares of the specialty chemicals company’s stock worth $5,036,000 after purchasing an additional 96,516 shares in the last quarter. Finally, Pzena Investment Management LLC lifted its position in shares of Olin by 17.5% during the fourth quarter. Pzena Investment Management LLC now owns 4,507,913 shares of the specialty chemicals company’s stock worth $93,900,000 after purchasing an additional 671,250 shares in the last quarter. Institutional investors and hedge funds own 88.67% of the company’s stock.
About Olin
Olin Corporation is a diversified manufacturer specializing in chemical products and ammunition. The company’s core business activities encompass the production and distribution of chlor-alkali products, epoxy resins and derivatives, and small-caliber ammunition under the Winchester brand. Olin’s chemical operations supply chlorine, caustic soda and related co-products to a wide range of end markets, including water treatment, pulp and paper, pharmaceuticals and general industrial applications.
In its Chlor Alkali Products & Vinyls segment, Olin operates multiple manufacturing facilities that produce chlorine and sodium hydroxide, along with vinyl chloride monomer and polyvinyl chloride (PVC) compounds.
Featured Stories
- Five stocks we like better than Olin
- AeroVironment’s Record Backlog and Earnings Beat Fuel Recovery Case
- Corning Just Locked In a Massive Verizon Fiber Deal as AI Infrastructure Expands
- 3 Under-$20 Stocks Tied to the Future of U.S. Energy and Materials
- Uncle Sam’s Quantum Leap: Feds Fund a $300M Quantum Supercycle
Receive News & Ratings for Olin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olin and related companies with MarketBeat.com's FREE daily email newsletter.
